US Patent Issued to 4C BIOMED, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES on July 21 for "Anti-HVEM antibodies and use thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,722, issued on July 21, was assigned to 4C BIOMED Ltd. (London) and TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (Ramat Gan, Israel).

"Anti-HVEM antibodies and use thereof" was invented by Eyal Greenberg (Even Yehuda, Israel), Gilli Galore-Haskel (Tel Mond, Israel), Efrat Merhavi-Shoham (Rehovot, Israel), Gal Markel (Ramat Gan, Israel) and Jacob Schachter (Givatayim, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Agents that bind HVEM, inhibit HVEM-BTLA interaction and activate downstream HVEM signaling are provided. Methods of treating disease with those agents and kits comprising those agents are also provided."

The paten...